CGRP Rezeptor Antagonisten

European patent · EP2488512 · In force

Register entry

Publication number
EP2488512
Application number
EP10768347
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 13, 2010
Published
Aug 22, 2012
Granted
Nov 27, 2013
Protection ends at the latest
Oct 12, 2030
Next annual fee due
Oct 31, 2027
IPC classes
C07D 401/12 (2006.01)
C07D 471/04 (2006.01)
C07D 471/10 (2006.01)
C07D 471/20 (2006.01)
A61K 31/473 (2006.01)
A61K 31/4704 (2006.01)
A61K 31/517 (2006.01)
A61K 31/519 (2006.01)
A61K 31/4745 (2006.01)
A61K 31/551 (2006.01)
A61K 31/4747 (2006.01)
A61P 25/06 (2006.01)
A61P 11/06 (2006.01)
Priority
US 251477 P 14.10.2009
PCT application
PCT/US2010/052433 13.10.2010
PCT publication
WO2011/046997 21.04.2011
Filing language
English
Source
Swissreg

Supplementary protection certificates

A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.

Rimegepant

C02488512/01 · Medicine · Granted · Protection from Oct 13, 2030 to Oct 12, 2035

Authorisation 69035 (Swissmedic, Oct 18, 2023)

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.10.2026 → 31.10.2027

    Published in Swissreg on 01.11.2026

  2. Nov 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.10.2025 → 31.10.2026

    Published in Swissreg on 01.11.2025

  3. Nov 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.10.2024 → 31.10.2025

    Published in Swissreg on 01.11.2024

  4. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  5. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  6. Dec 13, 2013

    Agent entered

    Representative
    Marks & Clerk (Luxembourg) LLP, Dreikönigstrasse 31a, 8002 Zürich

    Published in Swissreg on 13.12.2013

  7. Nov 27, 2013

    Granted

    Published in Swissreg on 27.11.2013

Parties

Holder

Bristol-Myers Squibb Company

Route 206 & Province Line Road, Princeton, NJ 08543-4000, US

Agent

Marks & Clerk (Luxembourg) LLP

Dreikönigstrasse 31a, 8002 Zürich

Inventor

LUO, Guanglin

Connecticut 06492, US

DUBOWCHIK, Gene M.

Connecticut 06492, US

MACOR, John E.

Connecticut 06492, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.